Search - tctmd.com

Displaying 241 - 260 of 626

Sort: Relevancy | Date

News Daily News

New on the Scene Nonstatin Drugs: Experts Provide Guidance

Caitlin E. Cox

August 31, 2022

News Conference News ESC 2022

Earlier Evolocumab Cut CVD, CV Mortality Over Longer Term: FOURIER-OLE

Michael O'Riordan

August 31, 2022

News Conference News ESC 2022

Polypill Bests Usual Care in Patients With Recent MI: SECURE

Michael O'Riordan

August 26, 2022

News Daily News

New USPSTF Statin Guidance: Familiar Advice, Some Holes to Fill

Shelley Wood

August 23, 2022

News Opinion Editor's Corner ESC 2022

What’s Going to Be Hot at ESC 2022?

Shelley Wood

August 22, 2022

News Features

Novel Targets, Gene Edits, and Vaccines: Is a ‘Golden Era’ Dawning for ASCVD?

Michael O'Riordan

August 15, 2022

News Daily News

Genetic Study Hints at Cognitive Impact of Statins, but Experts Urge Caution

Michael O'Riordan

August 11, 2022

News Daily News

Dapagliflozin Safe, Effective in Diabetes Regardless of Background CV Meds

Shelley Wood

July 25, 2022

News Daily News

CV Risk Factor Control Cuts Post-op Nursing Home Transfer for Black Americans

Yael L. Maxwell

July 22, 2022

News Daily News

Higher Subclinical Atherosclerosis in Black Americans Remains Unexplained

Yael L. Maxwell

July 15, 2022

News Daily News

LVEF Analysis Digs Anew Into Revascularization Benefits in Ischemic CAD

Michael O'Riordan

July 11, 2022

News Daily News

New Biomarker Data Again Draw Eyes to Mineral Oil in REDUCE-IT

Caitlin E. Cox

July 08, 2022

News Daily News

Comorbidities May Drive PAD Procedural Outcomes in Black Patients

L.A. McKeown

June 23, 2022

News Daily News

USPSTF: Most Vitamin, Supplement Data Still ‘Inconclusive’ on CVD Benefits

Yael L. Maxwell

June 23, 2022

News Daily News

Too Much Sitting Linked to Bad Outcomes Around the Globe: PURE

Michael O'Riordan

June 17, 2022

News Daily News

SURMOUNT-1: Tirzepatide Drastically Reduces Weight in Obese Patients

L.A. McKeown

June 09, 2022

News Conference News EAS 2022

Elevated Risks From Lp(a) Can Be Offset by Lower Lifetime LDL Cholesterol

Michael O'Riordan

May 26, 2022

News Conference News EAS 2022

FH Patients Face Unchanging Acute MI Risks Plus Very Late Diagnoses

Michael O'Riordan

May 26, 2022

News Conference News EAS 2022

Stepwise or Hammer Down? Experts Debate Best Approach to LDL-Lowering

Michael O'Riordan

May 24, 2022

News Conference News ESC Heart Failure 2022

Dapagliflozin Boosts Health Status Across LVEF Range

Shelley Wood

May 23, 2022

Advertisement

New on the Scene Nonstatin Drugs: Experts Provide Guidance

Earlier Evolocumab Cut CVD, CV Mortality Over Longer Term: FOURIER-OLE

Polypill Bests Usual Care in Patients With Recent MI: SECURE

New USPSTF Statin Guidance: Familiar Advice, Some Holes to Fill

What’s Going to Be Hot at ESC 2022?

Novel Targets, Gene Edits, and Vaccines: Is a ‘Golden Era’ Dawning for ASCVD?

Genetic Study Hints at Cognitive Impact of Statins, but Experts Urge Caution

Dapagliflozin Safe, Effective in Diabetes Regardless of Background CV Meds

CV Risk Factor Control Cuts Post-op Nursing Home Transfer for Black Americans

Higher Subclinical Atherosclerosis in Black Americans Remains Unexplained

LVEF Analysis Digs Anew Into Revascularization Benefits in Ischemic CAD

New Biomarker Data Again Draw Eyes to Mineral Oil in REDUCE-IT

Comorbidities May Drive PAD Procedural Outcomes in Black Patients

USPSTF: Most Vitamin, Supplement Data Still ‘Inconclusive’ on CVD Benefits

Too Much Sitting Linked to Bad Outcomes Around the Globe: PURE

SURMOUNT-1: Tirzepatide Drastically Reduces Weight in Obese Patients

Elevated Risks From Lp(a) Can Be Offset by Lower Lifetime LDL Cholesterol

FH Patients Face Unchanging Acute MI Risks Plus Very Late Diagnoses

Stepwise or Hammer Down? Experts Debate Best Approach to LDL-Lowering

Dapagliflozin Boosts Health Status Across LVEF Range

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content